EUROPEAN LIVER PATIENTS ASSOCIATION
- Country
- Belgium
- Type
- Beneficiary
- Grants received
- 13
Funding record
- 13 grants on record
- €1,228,466 awarded in total
- 2017–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
6 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
- EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER
- UNIVERSITY COLLEGE LONDON
- EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF)
- FUNDACIO DE RECERCA CLINIC BARCELONA-INSTITUT D INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
- ACADEMISCH ZIEKENHUIS LEIDEN
- HOSPITAL CLINIC DE BARCELONA
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Calls from this organisation
No published calls from this organisation.
Grants received
- Virus related biomarkers to improve management of chronic conditions
- AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients
- TUMOUR-HOST INTERACTIONS IN LIVER CANCER OF CHILDHOOD AND ADULTS
- GRIP on MASH: Global Research Initiative for Patient Screening on MASH
- Liver Electronic Offering Platform with Artificial intelligence-based Devices
- Unravelling the impact of Radiofrequency in liver surgery: the key to decrease local recurrence?
- Understanding Gene ENvironment Interaction in ALcohol-related hepatocellular carcinoma
- NOVEL TREATMENT OF ACUTE ON CHRONIC LIVER FAILURE USING SYNERGISTIC ACTION OF G-CSF AND TAK-242
- DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES
- Immune profiling to guide host-directed interventions to cure HBV infections
- Screening for liver fibrosis - population-based study across European countries
- MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response
- SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.